Your browser doesn't support javascript.
loading
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study.
Diéras, Véronique; Wildiers, Hans; Jassem, Jacek; Dirix, Luc Y; Guastalla, Jean-Paul; Bono, Petri; Hurvitz, Sara A; Gonçalves, Anthony; Romieu, Gilles; Limentani, Steven A; Jerusalem, Guy; Lakshmaiah, K C; Roché, Henri; Sánchez-Rovira, Pedro; Pienkowski, Tadeusz; Seguí Palmer, Miguel Ángel; Li, Ai; Sun, Yu-Nien; Pickett, Cheryl A; Slamon, Dennis J.
Afiliação
  • Diéras V; Institut Curie, Paris, France. Electronic address: veronique.dieras@curie.net.
  • Wildiers H; University Hospital Leuven, Leuven, Belgium. Electronic address: hans.wildiers@uzleuven.be.
  • Jassem J; Medical University of Gdansk, Gdansk, Poland. Electronic address: jjassem@gumed.edu.pl.
  • Dirix LY; General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: Luc.Dirix@gza.be.
  • Guastalla JP; Centre Léon Bérard, Lyon, France. Electronic address: GUASTALL@lyon.fnclcc.fr.
  • Bono P; Helsinki University Central Hospital, Helsinki, Finland. Electronic address: Petri.Bono@hus.fi.
  • Hurvitz SA; UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: SHurvitz@mednet.ucla.edu.
  • Gonçalves A; Institut Paoli-Calmettes, Marseilles, France. Electronic address: GONCALVESA@marseille.fnclcc.fr.
  • Romieu G; C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: gilles@romieu.info.
  • Limentani SA; Levine Cancer Institute, Charlotte, NC, USA. Electronic address: Steven.Limentani@carolinashealthcare.org.
  • Jerusalem G; CHU Sart Tilman, Liege, Belgium. Electronic address: g.jerusalem@chu.ulg.ac.be.
  • Lakshmaiah KC; Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: kcluck@gmail.com.
  • Roché H; Institut Claudius Régaud, Toulouse, France. Electronic address: Roche.Henri@claudiusregaud.fr.
  • Sánchez-Rovira P; Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: oncojaen@telefonica.net.
  • Pienkowski T; European Health Centre Otwock, Warszawa, Poland. Electronic address: tadeusz.pienkowski@gmail.com.
  • Seguí Palmer MÁ; Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: MSegui@tauli.cat.
  • Li A; Amgen Inc., Thousand Oaks, CA, USA. Electronic address: ail@amgen.com.
  • Sun YN; Amgen Inc., Thousand Oaks, CA, USA. Electronic address: yus@amgen.com.
  • Pickett CA; Amgen Inc., Thousand Oaks, CA, USA. Electronic address: cpickett@amgen.com.
  • Slamon DJ; UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: DSlamon@mednet.ucla.edu.
Breast ; 24(3): 182-90, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25747197
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Bevacizumab / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Bevacizumab / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article